EDIT:NASDAQ
Editas Medicine Inc
$1.86
arrow_downward
-0.27%(-0.0050) 1D
Nov 17, 10:32:07 AM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$1.90
High
$1.94
Low
$1.82
Mkt. cap
287.84M
Avg. vol.
2.41M
Volume
288.36K
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
Open
$1.90
High
$1.94
Low
$1.82
Mkt. cap
287.84M
Avg. vol.
2.41M
Volume
288.36K
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
News stories
From web sources and news partners
TradingView
·
2 hours ago
Stock Market Today: Dow Jones, S&P 500, Nasdaq 100 Futures Trade Mixed Ahead of Nvidia’s Q3 Earnings— CBRS, AMZN, RCAT in Focus (UPDATED)
The Motley Fool
·
1 hour ago
Prediction: Dec. 9 Will Mark a Turning Point for the S&P 500
Coinpaper
·
42 minutes ago
Stock Market Today: S&P 500 Struggles Ahead of Nvidia Earnings After $2 Trillion Stock Rout
Traders Union
·
1 hour ago
S&P 500 could deliver 18% total return by 2027, Goldman Sachs projects
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
FoundedNov 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com